Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Bone Neoplasms × Curettage × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 4 Chalazion 2 Recurrence 1 Pilonidal Sinus 1 Pain 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Chondrosarcoma 1 Chondroma 1 Carcinoma, Squamous Cell 1 Bone Neoplasms 1 Bone Cysts 1

Interventions

Gemcitabine 6 Doxorubicin 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 Docetaxel 3 Cyclophosphamide 3 Cisplatin 3 Vincristine 2 Tranexamic Acid 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Nivolumab 2 Methotrexate 2 Methods 2 Interviews as Topic 2 Indocyanine Green 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 tocilizumab 1 samarium Sm-153 lexidronam 1 regorafenib 1 poly ICLC 1 pegfilgrastim 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 fludarabine 1 flt3 ligand protein 1 endostar protein 1 eltrombopag 1 dinutuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02996747 2016-12-22

CONDRO1

Istituto Ortopedico Rizzoli

Bone Neoplasms, Chondroma, Chondrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡